PANACEA BIOTEC LTD.

NSE : PANACEABIOBSE : 531349ISIN CODE : INE922B01023Industry : Pharmaceuticals & DrugsHouse : Soshil Kumar Jain
BSE136.15-1.2 (-0.87 %)
PREV CLOSE ( ) 137.35
OPEN PRICE ( ) 137.25
BID PRICE (QTY) 135.65 (18)
OFFER PRICE (QTY) 136.25 (108)
VOLUME 2226
TODAY'S LOW / HIGH ( )134.70 137.25
52 WK LOW / HIGH ( )113.55 202.2
NSE135.80-1.65 (-1.2 %)
PREV CLOSE( ) 137.45
OPEN PRICE ( ) 135.80
BID PRICE (QTY) 135.40 (22)
OFFER PRICE (QTY) 135.90 (32)
VOLUME 36313
TODAY'S LOW / HIGH( ) 134.70 137.00
52 WK LOW / HIGH ( )114.2 202.5
Peer Companies Price () Chg () Chg (%) EPS () TTM P/E Volume (000's) 1 Year Return (%)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.